Sunday, October 6, 2024
10/6/2024
ABSTRACT. This K22 proposal aims to enhance the applicant’s prior quantitative training with a combination of formal coursework and informal guidance to transition to independence as a molecular cancer epidemiologist investigating the biological basis of health disparities in female cancers. Racial and ethnic disparities are well documented for ovarian cancer, the deadliest gynecological cancer. Black women, compared to White women, have higher odds of late stage diagnosis, and disproportionately worse survival rates despite lower incidence. Moreover, Black and Hispanic women have experienced slower decline rates in ovarian cancer mortality compared to White women. Social determinants of health only partially account for these disparities, suggesting that biological factors like the vaginal microbiome may play a non-trivial role. The vaginal microbiome can shape the tumor microenvironment through production of pro-carcinogenic metabolites and reduction of antineoplastic metabolites. However, its composition varies by host factors including race and ethnicity and correlates of social disadvantage such as poverty. While racially and ethnically distinct vaginal microbiomes may have unique metabolic profiles associated with differential ovarian cancer outcomes, no studies have evaluated this possibility. Therefore, applying the framework of Krieger’s ecosocial theory, we hypothesize that through embodiment of social disadvantage, racial and ethnic differences in the functional effects of the vaginal microbiome contribute to ovarian cancer disparities. We propose a study that will use an untargeted metabolomics approach to compare metabolite profiles of cervicovaginal fluid from 120 patients (40 Black, 40 Hispanic, and 40 White), by race and ethnicity and by social disadvantage. To test our central hypothesis, we have set three specific aims, namely to, i) characterize racial and ethnic differences in vaginal fluid metabolite profiles, and metabolic signatures among OC patients , ii) assess differences by social disadvantage in vaginal fluid metabolite profiles, and metabolic signatures among OC patients, at the individual and neighborhood levels, and iii) evaluate the relative importance of vaginal fluid metabolites and social disadvantage on OC aggressiveness, and OC recurrence. Completion of the proposed K22 will enhance scientific knowledge on the role of vaginal microbiome-induced inflammation in ovarian cancer progression. This study will identify biological pathways that contribute to racial and ethnic differences in ovarian cancer progression. This scientific knowledge will be useful for identifying metabolites that can serve as prognostic biomarkers for ovarian cancer, and designing future mechanistic studies. Moreover, at the clinical level, our study will provide evidence on how therapeutic interventions that involve modulating the vaginal microbiome may be beneficial for specific races and ethnicities, and indicate the potential value of applying vaginal microbiome metabolite profiling in clinical settings. The proposed K22 study will provide the applicant with the necessary training, skills and resources to transition to independence as a molecular cancer epidemiologist.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).
